CME Group Inc.
US ˙ NasdaqGS ˙ US12572Q1058

SecurityCME / CME Group Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in CME / CME Group Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of CME Group Inc. (US:CME) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 485,738 shares of CME Group Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 0 -100.00 0
2025-08-14 2025-06-30 13F CME GROUP COM 12572Q105 485,738 -91,304 -15.82 133,879 -12.54 0.3846
2025-05-15 2025-03-31 13F CME GROUP COM 12572Q105 577,042 51,689 9.84 153,083 25.48 0.5028
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 525,353 -50,309 -8.74 122,003 -3.95 0.3706
2024-11-14 2024-09-30 13F CME GROUP COM 12572Q105 575,662 81,058 16.39 127,020 30.63 0.3761
2025-02-25 2024-06-30 13F/A-1 CME GROUP COM 12572Q105 494,604 204,147 70.28 97,239 55.50 0.2893
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 494,604 204,147 97,239 0.2893
2024-05-15 2024-03-31 13F CME GROUP COM 12572Q105 290,457 14,563 5.28 62,532 7.62 0.1874
2024-07-16 2023-12-31 13F/A-1 CME GROUP COM 12572Q105 275,894 5,371 1.99 58,103 7.27 0.1874
2024-02-14 2023-12-31 13F CME GROUP COM 12572Q105 275,894 5,371 58,103 0.1138
2023-11-14 2023-09-30 13F CME GROUP COM 12572Q105 270,523 -16,389 -5.71 54,164 1.89 0.1904
2023-08-14 2023-06-30 13F CME GROUP COM 12572Q105 286,912 7,947 2.85 53,162 -0.50 0.1767
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 278,965 -1,367 -0.49 53,427 13.34 0.1838
2023-02-14 2022-12-31 13F CME GROUP COM 12572Q105 280,332 -32,149 -10.29 47,141 -14.83 0.1701
2023-02-14 2022-09-30 13F/A-1 CME Group COM 12572Q105 312,481 -41,350 -11.69 55,350 -23.58 0.2178
2022-11-14 2022-09-30 13F CME Group COM 12572Q105 312,481 -41,350 55,350 0.2178
2023-02-14 2022-06-30 13F/A-1 CME Group COM 12572Q105 353,831 -50,742 -12.54 72,429 -24.73 0.2684
2022-08-15 2022-06-30 13F CME Group COM 12572Q105 353,831 -50,742 72,429 0.2684
2023-02-14 2022-03-31 13F/A-1 CME Group COM 12572Q105 404,573 73,474 22.19 96,232 27.22 0.2735
2022-05-13 2022-03-31 13F CME Group COM 12572Q105 404,573 73,474 96,231 0.2735
2022-02-14 2021-12-31 13F CME Group COM 12572Q105 331,099 69,167 26.41 75,643 49.34 0.1934
2021-11-15 2021-09-30 13F CME Group COM 12572Q105 261,932 -4,425 -1.66 50,651 -10.59 0.1421
2021-08-13 2021-06-30 13F/A-1 CME Group COM 12572Q105 266,357 -10,645 -3.84 56,649 0.14 0.1597
2021-08-13 2021-06-30 13F CME Group COM 12572Q105 266,357 -10,645 56,649 0.0956
2021-05-14 2021-03-31 13F CME Group COM 12572Q105 277,002 -2,482 -0.89 56,572 11.19 0.1723
2021-02-12 2020-12-31 13F CME Group COM 12572Q105 279,484 76,560 37.73 50,880 49.86 0.1597
2021-02-11 2020-09-30 13F/A-1 CME Group COM 12572Q105 202,924 -90,384 -30.82 33,951 -28.79 0.1227
2020-11-13 2020-09-30 13F CME Group COM 12572Q105 202,924 -90,384 33,951 67,771.5844
2021-02-12 2020-06-30 13F/A-1 CME GROUP COM 12572Q105 293,308 12,089 4.30 47,675 -1.96 0.1878
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 293,308 12,089 47,675 188,013.3197
2021-02-12 2020-03-31 13F/A-2 CME GROUP COM 12572Q105 281,219 55,453 24.56 48,626 7.30 0.2430
2020-06-15 2020-03-31 13F/A-1 CME GROUP COM 12572Q105 281,219 0 48,626 0.2432
2020-05-15 2020-03-31 13F CME GROUP COM 12572Q105 281,734 55,968 48,715 135,477.2529
2021-02-12 2019-12-31 13F/A-1 CME GROUP COM 12572Q105 225,766 47,412 26.58 45,316 20.22 0.1843
2020-02-18 2019-12-31 13F CME GROUP COM 12572Q105 225,766 47,412 45,316 184,511.2579
2021-02-12 2019-09-30 13F/A-1 CME GROUP COM 12572Q105 178,354 -22,415 -11.16 37,693 -3.28 0.1500
2019-11-14 2019-09-30 13F CME GROUP COM 12572Q105 178,354 -22,415 37,693 150,209.0046
2021-02-12 2019-06-30 13F/A-1 CME GROUP COM 12572Q105 200,769 9,434 4.93 38,971 23.76 0.1521
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 200,769 9,434 38,971 152,827.8705
2019-05-14 2019-03-31 13F CME GROUP COM CL A 12572Q105 191,335 -16,873 -8.10 31,490 -19.60 0.1231
2019-02-13 2018-12-31 13F CME GROUP COM CL A 12572Q105 208,208 -35,683 -14.63 39,168 -5.65 0.1707
2018-11-08 2018-09-30 13F CME GROUP COM CL A 12572Q105 243,891 27,079 12.49 41,513 16.81 0.1523
2018-08-13 2018-06-30 13F CME GROUP COM CL A 12572Q105 216,812 4,211 1.98 35,539 3.35 0.1362
2018-05-14 2018-03-31 13F CME GROUP COM CL A 12572Q105 212,601 -37,117 -14.86 34,386 -5.72 0.1372
2018-02-13 2017-12-31 13F CME GROUP COM CL A 12572Q105 249,718 -10,056 -3.87 36,471 3.48 0.1432
2017-12-01 2017-09-30 13F/A-1 CME GROUP COM CL A 12572Q105 259,774 17,474 7.21 35,246 16.15 0.1518
2017-11-13 2017-09-30 13F CME GROUP COM CL A 12572Q105 259,774 17,474 35,246
2017-08-10 2017-06-30 13F CME GROUP COM 12572Q105 242,300 35,800 17.34 30,346 23.70 0.1378
2017-05-11 2017-03-31 13F CME GROUP COM 12572Q105 206,500 75,200 57.27 24,532 61.97 0.1108
2017-02-13 2016-12-31 13F CME GROUP COM 12572Q105 131,300 10,900 9.05 15,146 20.35 0.0711
2016-11-10 2016-09-30 13F CME GROUP COM 12572Q105 120,400 45,600 60.96 12,585 72.73 0.0553
2016-08-11 2016-06-30 13F CME GROUP COM 12572Q105 74,800 800 1.08 7,286 2.50 0.0325
2016-05-13 2016-03-31 13F CME GROUP COM 12572Q105 74,000 4,200 6.02 7,108 12.40 0.0319
2016-02-12 2015-12-31 13F CME GROUP COM 12572Q105 69,800 4,200 6.40 6,324 3.94 0.0276
2015-11-13 2015-09-30 13F CME GROUP COM 12572Q105 65,600 0 0.00 6,084 -0.34 0.0249
2015-08-13 2015-06-30 13F CME GROUP COM 12572Q105 65,600 -17,100 -20.68 6,105 -22.06 0.0244
2015-05-13 2015-03-31 13F CME GROUP COM 12572Q105 82,700 37,200 81.76 7,833 94.17 0.0323
2015-02-13 2014-12-31 13F CME GROUP COM 12572Q105 45,500 44,000 2,933.33 4,034 3,261.67 0.0162
2014-11-13 2014-09-30 13F CME GROUP COM 12572Q105 1,500 0 0.00 120 13.21 0.0005
2014-08-13 2014-06-30 13F CME GROUP COM 12572Q105 1,500 -500 -25.00 106 -28.38 0.0004
2014-05-13 2014-03-31 13F CME GROUP COM 12572Q105 2,000 -21,300 -91.42 148 -91.90 0.0006
2014-02-13 2013-12-31 13F CME GROUP COM 12572Q105 23,300 6,100 35.47 1,828 43.82 0.0082
2013-11-13 2013-09-30 13F CME GROUP COM 12572Q105 17,200 -233 -1.34 1,271 -4.08 0.0063
2013-08-12 2013-06-30 13F CME GROUP COM 12572Q105 17,433 17,433 1,325 0.0070
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.